| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.06 |